Australia
Australia eClinical Solutions Market Industry Trends and Forecast to 2034: Segmented by (Product, Deployment, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Australia · 2024–2034 · estimates
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
China at $994.1 Mn.
India at 16% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$457.1 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $161.6 Mn | — | — |
| 2025 (base) | $185.6 Mn | +$23.9 Mn | — |
| 2026 (forecast) | $213.0 Mn | +$27.5 Mn | +14.8% |
| 2027 (forecast) | $244.6 Mn | +$31.5 Mn | +31.8% |
| 2028 (forecast) | $280.7 Mn | +$36.2 Mn | +51.3% |
| 2029 (forecast) | $322.3 Mn | +$41.6 Mn | +73.7% |
| 2030 (forecast) | $370.0 Mn | +$47.7 Mn | +99.4% |
| 2031 (forecast) | $424.8 Mn | +$54.8 Mn | +128.9% |
| 2032 (forecast) | $487.6 Mn | +$62.9 Mn | +162.8% |
| 2033 (forecast) | $559.8 Mn | +$72.2 Mn | +201.7% |
| 2034 (forecast) | $642.6 Mn | +$82.8 Mn | +246.3% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US
$6.27 Bn
Canada
$1.20 Bn
China
$994.1 Mn
Japan
$758.3 Mn
Germany
$466.2 Mn
France
$422.5 Mn
Brazil
$404.7 Mn
UK
$379.3 Mn
Italy
$319.6 Mn
Ecuador
$257.8 Mn
India
$269.8 Mn
Spain
$235.0 Mn
Saudi Arabia
$242.3 Mn
Mexico
$205.7 Mn
Australia (this report)
$185.6 Mn
Russia
$152.7 Mn
New Zealand
$120.4 Mn
South Africa
$106.3 Mn
UAE
$69.9 Mn
Egypt
$43.1 Mn
Philippines
$30.7 Mn
Hong Kong
$24.4 Mn
Malaysia
$19.7 Mn
Thailand
$15.4 Mn
Singapore
$15.1 Mn
Kenya
$10.5 Mn
eClinical solutions are software for running clinical trials, such as data capture, randomisation, trial management and e-consent.
Key segments of the eClinical Solutions market include product (EDC, CTMS and RTSM) and deployment (Cloud and On-Premise).
Growing drug pipelines, more complex biologics, cost pressure on drug makers and the need for speed are driving the eClinical Solutions market. Many companies now outsource work they used to do in-house.
Advanced therapies, AI-driven operations and expansion in India, China and Southeast Asia give the eClinical Solutions market room to grow.
Capacity shortages, strict quality rules, data security concerns and pricing pressure hold back the eClinical Solutions market.
The eClinical Solutions market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the eClinical Solutions market. Government digital health programs in Australia are speeding up adoption.
What doctors and scientists are doing in eClinical Solutions right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Australia · 2 shared keywords
Australia · 2 shared keywords
Australia · 2 shared keywords
Australia · 2 shared keywords
Australia · 2 shared keywords
Australia · 2 shared keywords
Healthcare Services · Australia
Healthcare Services · Australia
Healthcare Services · Australia
Healthcare Services · Australia
Healthcare Services · Australia
Healthcare Services · Australia